BIOLOGICAL · Unmapped registry intervention
VY-AADC01
Find medicine records ·
Find other trials using this name
Clinical trial
Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease
NCT01973543
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedSafety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Parkinson's Diseaseverified · MONDO: Parkinson disease
Interventions
VY-AADC01BIOLOGICAL
Sponsors & collaborators
Neurocrine Bioscienceslead sponsor
University of California, San Franciscocollaborator
Veristat, Inc.collaborator
Feinstein Institute for Medical Researchcollaborator
Oregon Health and Science Universitycollaborator
Voyager Therapeuticscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01973543 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.